SACUBITRIL AND VALSARTAN vs TELMISARTAN AND HYDROCHLOROTHIAZIDE

Compare SACUBITRIL AND VALSARTAN (ARB) and TELMISARTAN AND HYDROCHLOROTHIAZIDE (telmisartan and hydrochlorothiazide) — clinical data, side effects, and patient experiences.

SACUBITRIL AND VALSARTAN

· ARB

How it works

12.1 Mechanism of Action ENTRESTO contains a neprilysin inhibitor, sacubitril, and an angiotensin receptor blocker, valsartan. ENTRESTO inhibits neprilysin (neutral endopeptidase; ...

Approved for

1 INDICATIONS AND USAGE ENTRESTO is a combination of sacubitril

a neprilisin inhibitor

and valsartan

an angiotensin II receptor blocker

OralTablet

TELMISARTAN AND HYDROCHLOROTHIAZIDE

telmisartan and hydrochlorothiazide · ARB

How it works

ARB agent

Approved for

1 INDICATIONS AND USAGE Telmisartan and hydrochlorothiazide tablets are indicated for the treatment of hypertension

to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events

including

as appropriate

OralTablet

Quick Comparison

SACUBITRIL AND VALSARTANTELMISARTAN AND HYDROCHLOROTHIAZIDE

Drug Class

ARB

Route

Oral

Half-Life

—

FDA Approved

—

Side Effect Frequency Comparison

Estimated frequency (%) based on clinical trial data

Side Effects

SACUBITRIL AND VALSARTAN

Low Blood Pressure

>10%

Shortness of Breath

1-10%

Fatigue

1-10%

Cough

1-10%

Weight Loss

1-10%

General Unwellness

0.1-1%

Weight Gain

0.1-1%

Dizziness

1-10%

TELMISARTAN AND HYDROCHLOROTHIAZIDE

Nausea

1-10%

Fatigue

1-10%

Drug Not Working

1-10%

Diarrhea

1-10%

Shortness of Breath

1-10%

Headache

1-10%

Dizziness

1-10%

Falls

1-10%

FDA Warnings

SACUBITRIL AND VALSARTAN

5 WARNINGS AND PRECAUTIONS Observe for signs and symptoms of angioedema and hypotension
Use of drugs that act on the renin-angiotensin system during the second and third trimesters of pregnancy reduces fetal renal function and increases fetal and neonatal morbidity and death
However, if there is no appropriate alternative to therapy with drugs affecting the renin-angiotensin system, and if the drug is considered lifesaving for the mother, advise a pregnant woman of the potential risk to the fetus [see Use in Specific Populations (8
Angioedema associated with laryngeal edema may be fatal

TELMISARTAN AND HYDROCHLOROTHIAZIDE

5 WARNINGS AND PRECAUTIONS Avoid fetal or neonatal exposure (5
1 Fetal Toxicity Telmisartan Use of drugs that act on the renin-angiotensin system during the second and third trimesters of pregnancy reduces fetal renal function and increases fetal and neonatal morbidity and death
Potential neonatal adverse effects include skull hypoplasia, anuria, hypotension, renal failure, and death
, patients with renal artery stenosis, chronic kidney disease, severe congestive heart failure, or volume depletion) may be at particular risk of developing oliguria, progressive azotemia, or acute renal failure on telmisartan and hydrochlorothiazide

Clinical Trial Data

No head-to-head clinical studies found for SACUBITRIL AND VALSARTAN vs TELMISARTAN AND HYDROCHLOROTHIAZIDE.

SACUBITRIL AND VALSARTAN vs TELMISARTAN AND HYDROCHLOROTHIAZIDE: What You Should Know

Key Differences

Both SACUBITRIL AND VALSARTAN and TELMISARTAN AND HYDROCHLOROTHIAZIDE belong to the ARB class. While they share a similar mechanism of action, differences in pharmacokinetics, dosing, and side effect profiles may make one more suitable than the other for individual patients.

Safety Considerations

SACUBITRIL AND VALSARTAN carries 4 FDA warnings. TELMISARTAN AND HYDROCHLOROTHIAZIDE carries 4 FDA warnings. Patients should discuss all warnings and contraindications with their healthcare provider before starting or switching medications..

This comparison is for informational purposes only. Always consult a qualified healthcare professional before making medication decisions.

Related Comparisons

SACUBITRIL AND VALSARTAN vs VALSARTAN→IRBESARTAN vs SACUBITRIL AND VALSARTAN→SACUBITRIL AND VALSARTAN vs VALSARTAN AND HYDROCHLOROTHIAZIDE→SACUBITRIL AND VALSARTAN vs TELMISARTAN→IRBESARTAN AND HYDROCHLOROTHIAZIDE vs SACUBITRIL AND VALSARTAN→SACUBITRIL AND VALSARTAN vs TELMISARTAN AND AMLODIPINE→

Loading comparison data...

SACUBITRIL AND VALSARTAN vs TELMISARTAN AND HYDROCHLOROTHIAZIDE

Compare SACUBITRIL AND VALSARTAN (ARB) and TELMISARTAN AND HYDROCHLOROTHIAZIDE (telmisartan and hydrochlorothiazide) — clinical data, side effects, and patient experiences.

SACUBITRIL AND VALSARTAN

· ARB

How it works

12.1 Mechanism of Action ENTRESTO contains a neprilysin inhibitor, sacubitril, and an angiotensin receptor blocker, valsartan. ENTRESTO inhibits neprilysin (neutral endopeptidase; ...

Approved for

1 INDICATIONS AND USAGE ENTRESTO is a combination of sacubitril

a neprilisin inhibitor

and valsartan

an angiotensin II receptor blocker

OralTablet

TELMISARTAN AND HYDROCHLOROTHIAZIDE

telmisartan and hydrochlorothiazide · ARB

How it works

ARB agent

Approved for

1 INDICATIONS AND USAGE Telmisartan and hydrochlorothiazide tablets are indicated for the treatment of hypertension

to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events

including

as appropriate

OralTablet

Quick Comparison

SACUBITRIL AND VALSARTANTELMISARTAN AND HYDROCHLOROTHIAZIDE

Drug Class

ARB

Route

Oral

Half-Life

—

FDA Approved

—

Side Effect Frequency Comparison

Estimated frequency (%) based on clinical trial data

Side Effects

SACUBITRIL AND VALSARTAN

Low Blood Pressure

>10%

Shortness of Breath

1-10%

Fatigue

1-10%

Cough

1-10%

Weight Loss

1-10%

General Unwellness

0.1-1%

Weight Gain

0.1-1%

Dizziness

1-10%

TELMISARTAN AND HYDROCHLOROTHIAZIDE

Nausea

1-10%

Fatigue

1-10%

Drug Not Working

1-10%

Diarrhea

1-10%

Shortness of Breath

1-10%

Headache

1-10%

Dizziness

1-10%

Falls

1-10%

FDA Warnings

SACUBITRIL AND VALSARTAN

5 WARNINGS AND PRECAUTIONS Observe for signs and symptoms of angioedema and hypotension
Use of drugs that act on the renin-angiotensin system during the second and third trimesters of pregnancy reduces fetal renal function and increases fetal and neonatal morbidity and death
However, if there is no appropriate alternative to therapy with drugs affecting the renin-angiotensin system, and if the drug is considered lifesaving for the mother, advise a pregnant woman of the potential risk to the fetus [see Use in Specific Populations (8
Angioedema associated with laryngeal edema may be fatal

TELMISARTAN AND HYDROCHLOROTHIAZIDE

5 WARNINGS AND PRECAUTIONS Avoid fetal or neonatal exposure (5
1 Fetal Toxicity Telmisartan Use of drugs that act on the renin-angiotensin system during the second and third trimesters of pregnancy reduces fetal renal function and increases fetal and neonatal morbidity and death
Potential neonatal adverse effects include skull hypoplasia, anuria, hypotension, renal failure, and death
, patients with renal artery stenosis, chronic kidney disease, severe congestive heart failure, or volume depletion) may be at particular risk of developing oliguria, progressive azotemia, or acute renal failure on telmisartan and hydrochlorothiazide

Clinical Trial Data

No head-to-head clinical studies found for SACUBITRIL AND VALSARTAN vs TELMISARTAN AND HYDROCHLOROTHIAZIDE.

SACUBITRIL AND VALSARTAN vs TELMISARTAN AND HYDROCHLOROTHIAZIDE: What You Should Know

Key Differences

Safety Considerations

This comparison is for informational purposes only. Always consult a qualified healthcare professional before making medication decisions.